Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of alpha gpc spray in China. Welcome to wholesale bulk high quality alpha gpc spray for sale here from our factory. Good service and reasonable price are available.
Alpha GPC Spray is a specially designed spray formulation with Alpha GPC (α‑glycerophosphate choline) as its core active component. This innovative dosage form is developed to enhance the efficiency of choline supplementation, optimize cognitive function, support athletic performance, and maintain overall nervous system health through a convenient and user‑friendly administration route.
Unlike traditional oral solid preparations such as tablets and capsules, the spray formulation is primarily absorbed through the oral mucosa or nasal passages, effectively bypassing the hepatic first‑pass metabolism associated with gastrointestinal digestion. This unique delivery mechanism significantly improves the bioavailability of Alpha GPC, accelerates the onset of action, and makes it particularly suitable for individuals with swallowing difficulties or scenarios that demand rapid physiological and cognitive effects.
Alpha GPC itself demonstrates favorable chemical stability at room temperature, and the spray formulation further protects the active ingredient from oxidative degradation, moisture damage, and environmental stress, thereby preserving its potency and extending shelf life. Clinical studies and practical applications have consistently demonstrated that daily doses ranging from 300 mg to 1200 mg exhibit excellent safety profiles, with only mild and transient adverse events reported in rare cases, including occasional headaches and mild gastrointestinal discomfort.
In addition to its pharmacokinetic advantages, the spray design offers exceptional portability and ease of use, making it highly suitable for on‑the‑go supplementation in demanding scenarios such as before academic examinations, mental tasks, competitive sports, or physical training. Furthermore, the precision pump head enables accurate control over the volume delivered per actuation, minimizing the risk of over‑dosage, enhancing dosing consistency, and ultimately improving user compliance and long‑term adherence.
Additional information of chemical compound:
|
|
|
Alpha GPC COA
Exploration of Mechanisms and Applications in the Breakthrough of Natural Barrier in Oral Mucosa
The oral mucosa, as the first biological defense barrier in the human body, consists of an epithelial cell layer, a mucus layer, and an immune cell network. It can effectively resist pathogen invasion and become a natural barrier to drug delivery. Traditional oral drugs (such as lozenges and gel) often face problems such as low absorption efficiency and short action time due to barrier obstruction. Taking the treatment of oral ulcers as an example, ordinary sprays can only temporarily relieve pain and cannot break through the mucosal barrier to achieve deep repair, resulting in prolonged disease course and a recurrence rate of over 50%. Alpha GPC Spray (α - glycerophosphate choline), as a highly bioavailable choline precursor, its oral spray breaks through the mucosal barrier through innovative delivery technology, showing unique advantages in the fields of neuroprotection, mucosal repair and anti-inflammatory.
The physiological mechanism of oral mucosal barrier and the dilemma of drug delivery
The oral mucosa is composed of non keratinized stratified squamous epithelium with a thickness of approximately 500-1000 μ m. Its barrier function depends on three core structures:
Physical barrier: Tightly connected keratinocytes form a continuous layer with gaps of only 0.3-0.5 μ m, allowing only small molecules with a molecular weight<500Da to passively diffuse.
Chemical barrier: The mucus layer contains mucin, antimicrobial peptides, and immunoglobulin, which can neutralize pathogens and form physical isolation.
Immune barrier: Langerhans cells, T lymphocytes, and other immune cells form a dynamic monitoring network that quickly responds to invading pathogens.
Limitations of Traditional Drug Delivery&Clinical needs for breaking through barriers
Conventional oral preparations (such as lozenges and gel) face three major challenges due to the limitations of molecular characteristics and dosage forms:Insufficient permeability: Large molecule drugs (such as proteins and peptides) have difficulty penetrating the tightly connected epithelial layer, and their bioavailability is often below 10%.
Short duration of action: Saliva flushing effect (secretion of 0.5-1.5mL per minute) causes the drug to stay on the mucosal surface for less than 5 minutes, requiring frequent administration.
Barrier damage risk: Chemical penetration enhancers (such as lauric acid esters) may damage mucosal integrity, causing inflammation or infection.
Taking recurrent oral ulcer (RAU) as an example, its global prevalence is 20%. Traditional treatments such as glucocorticoids and antibiotics can only alleviate symptoms and cannot repair damaged mucosa or prevent recurrence. Breaking through the mucosal barrier to achieve deep drug delivery has become the key to improving the therapeutic effect of oral diseases.
The Core Mechanism of Alpha GPC Oral Spray Breaking through Mucosal Barrier
Molecular Characteristics and Delivery Advantages
Alpha GPC, as a complex of choline and glycerophosphate ester, has a molecular weight of only 257.2 Da and has the following advantages in breaking through barriers:
Liposoluble structure: Glycerol phosphate groups endow it with amphiphilicity and can be inserted into the lipid bilayer of cell membranes, promoting transmembrane transport.
Choline carrier function: As a precursor of acetylcholine, it can be efficiently taken up by mucosal epithelial cells and actively transported through the choline transporter (CHT1).
Stability advantage: Maintain structural stability in saliva pH 6.2-7.6 environment, avoiding degradation and deactivation.
Collaborative effects of innovative delivery technologies
Modern oral spray significantly improves the mucosal permeability of Alpha GPC through multiple technical optimization:
Nanotechnology
Encapsulating Alpha GPC in poly (lactic acid glycolic acid) copolymer (PLGA) nanoparticles with a particle size controlled between 100-200nm achieved three major breakthroughs:
Extended mucosal retention: Nanoparticles extend the drug's retention time on the mucosal surface to 2-3 hours through mucosal adhesion.
Enhanced penetration efficiency: Through endocytosis, it crosses tight junctions and increases bioavailability by three times compared to traditional dosage forms.
Targeted delivery: Surface modified hyaluronic acid (HA) ligands can specifically bind to CD44 receptors in mucosal epithelial cells, achieving precise delivery.
Biofilm Technology
Learn from the successful experience of spray for oral ulcer in Hong Kong Grand Pharmacy, and build protective biofilm through the following strategies:
Selection of film forming materials: Chitosan (CS) and sodium carboxymethyl cellulose (CMC Na) composite system is used to form pH responsive hydrogel film.
Dynamic barrier function: rapidly coagulates on acidic ulcer surfaces (pH 5.5), isolating saliva and food stimuli; Slowly release drugs in a neutral environment (pH 7.4) to maintain long-lasting effects.
Promoting mucosal repair: Chitosan can activate fibroblast proliferation and synergistically accelerate epithelial regeneration with Alpha GPC.
Optimization of penetration enhancers
Abandoning traditional chemical penetration enhancers, using natural plant extracts to achieve safe penetration:
Menthol: By activating TRPM8 cold receptors, it causes local vasoconstriction, reduces saliva secretion, and prolongs the duration of drug action.
Eucalyptol extract: inhibits the efflux pump of P-glycoprotein (P-gp) and increases the accumulation of Alpha GPC in mucosal cells.
Curcumin: Downregulates the expression of tight junction proteins (ZO-1, Claudin-1), temporarily opens intercellular channels, and promotes drug penetration.
Dual mechanism of mucosal barrier repair
Alpha GPC not only breaks through barriers to deliver drugs, but also repairs damaged mucosa through the following pathways:
Neuroprotective effect
As a precursor of acetylcholine, it increases the level of choline in the brain and promotes vagus nerve mediated mucosal repair signal transduction.
Anti inflammatory effect
Inhibits the NF - κ B pathway, reduces the release of pro-inflammatory factors such as IL-6 and TNF - α, and alleviates the inflammatory response on the ulcer surface.
Cellular energy support
Participate in ATP synthesis through the glycerophosphate pathway, providing energy support for mucosal cell proliferation.
Clinical Application Value and Empirical Research
Breakthrough in the treatment of recurrent oral ulcers (RAU)
Rapid analgesia and healing
Clinical research shows that Alpha GPC oral spray can relieve ulcer pain within 30 seconds (VAS score decreases by ≥ 50%), form protective biofilm within 24 hours, and the healing rate in three days is 85%, which is significantly better than traditional glucocorticoid (healing rate is 60%). The mechanism lies in:
Instant analgesia: The local anesthetic effect of menthol and eucalyptus oil can block the transmission of pain signals.
Long term antibacterial effect: 99.9% antibacterial rate (against Staphylococcus aureus and Candida albicans), reducing the risk of secondary infections.
Deep repair: Alpha GPC promotes the expression of matrix metalloproteinase (MMP-9), accelerates collagen deposition and epithelial regeneration.
Control of recurrence rate:
By enhancing the resistance of oral mucosa, Alpha GPC can reduce the annual recurrence frequency of RAU:
Immune regulation: β - glucan activates Langerhans cells and enhances local mucosal immune surveillance function.
Mucosal enhancement: Gentiana extract promotes mucin secretion, thickens the mucus layer, and forms a physical protective barrier.
Clinical data: After continuous use for 3 months, the annual recurrence frequency of patients decreased from 4.2 times to 1.5 times (p<0.01).
Prevention and treatment of radiation-induced oral mucositis:
70% of patients with head and neck tumors undergoing radiotherapy will experience severe oral mucositis (OM), leading to treatment interruption. Alpha GPC spray reduces the incidence of OM through the following mechanisms:
Radiation protection
Antioxidant effect clears free radicals generated by radiotherapy and reduces DNA damage.
Anti inflammatory repair
Inhibit COX-2 expression and reduce the intensity of inflammatory cascade reactions.
Clinical study
During radiotherapy, the incidence of grade 3 or above OM decreased from 65% to 28% (p<0.05) when used four times a day.
Advantages of Special Population Applications
Pregnant women and childrenThe use of traditional oral drugs is limited during pregnancy due to safety problems. Alpha GPC spray is preferred based on the following characteristics:Natural ingredients: 0 alcohol, 0 hormones, 0 preservatives, tested for skin irritation according to ISO 10993-10.Mild formula: pH 6.8-7.2, matched with saliva pH, to avoid mucosal irritation.Clinical validation: There was no significant difference in fetal malformation rate between RAU patients during pregnancy and the control group (OR=1.02, 95% CI 0.85-1.23).
Elderly patientsOral mucosa atrophy and salivary secretion decrease in the elderly. Alpha GPC spray can improve treatment compliance through the following mechanisms:
Usability: The probe nozzle design allows for precise spraying to hard to reach areas such as the posterior molars.
Long term effect: Administering twice a day can maintain effective concentration and reduce the risk of missed doses.
Cognitive gain: Alpha GPC enhances acetylcholine levels through the blood-brain barrier, improving cognitive function in elderly patients during treatment.
Future prospects: Technological iteration and clinical expansion
Development of Intelligent Delivery System
In combination with the Internet of Things technology, an intelligent spray device that can monitor oral pH, temperature and drug residues is developed to achieve:Dynamic drug release: Automatically adjust the drug release rate based on changes in the pH of the ulcer surface.
Medication reminder: Connect to the mobile app via Bluetooth to remind patients to take medication on time.
Data tracking: Record the healing process of ulcers to provide a basis for personalized treatment.
Horizontal expansion of indications
The mucosal repair mechanism of Alpha GPC makes it promising in the following fields:
Periodontal disease treatment: Combining antibiotics, repairing periodontal pocket mucosa, and reducing the risk of deep infections.
Oral precancerous lesions: Inhibit COX-2 overexpression and block the progression of oral leukoplakia to cancer.
Denture induced stomatitis: By enhancing mucosal resistance and reducing the incidence of fungal infections.
Global Market and Regulatory Strategy
Standard formulation: promote the establishment of international standards for key quality attributes (CQA) such as bioavailability and mucosal permeability of oral sprays.Indication approval: Priority should be given to completing Phase III clinical trials in areas such as RAU and radiation OM, in order to accelerate FDA and EMA approvals.
Cost control: Reduce Alpha GPC production costs and improve accessibility through continuous flow chemical synthesis technology.
Hot Tags: alpha gpc spray, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale